Founded in partnership with the University of California, San Francisco, ITI is pioneering novel approaches to illuminating the underlying biology of immune-related disease and mechanisms of drug action with a goal to discover and develop novel high value biomarkers that more effectively guide new drug development and match patients with therapies that will provide them the greatest benefit.